Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1842 News Items found In the Lab Investigators Sequence the Genome of a Rare Head and Neck Cancer Friday, May 24, 2013 Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering. Honors Three Memorial-Sloan Kettering Researchers Receive Special Awards by the American Society of Clinical Oncology Wednesday, May 22, 2013 Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers. Event Pulitzer Prize-winning Author Siddhartha Mukherjee Addresses 2013 Graduates Friday, May 17, 2013 Physician-scientist Siddhartha Mukherjee, author of <em>The Emperor of All Maladies: A Biography of Cancer</em>, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery. Snapshot Pigment-Producing Skin Cells Generated Using Stem Cell Technology Tuesday, May 14, 2013 Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer. Honors Structural Biologist Christopher Lima Named Howard Hughes Medical Institute Investigator Thursday, May 9, 2013 Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years. In the Lab Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer Tuesday, April 30, 2013 Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide. Imagination to Discovery Monday, April 1, 2013 Three emerging investigators are tackling the mysteries of biology and cancer at Memorial Sloan Kettering. Finding New Findings May Lead to Better Predictions of Breast Cancer Risk in Women with Inherited Mutations Thursday, March 28, 2013 A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation. In the Clinic Cell-Based Immune Therapy Shows Promise in Leukemia Patients Wednesday, March 20, 2013 Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia. In the Lab New Molecule Targets Proteins Inside Cancer Cells Wednesday, March 13, 2013 Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment